NeuroSense Therapeutics Ltd. (NRSNW) Warrants
Each NRSNW warrant gives the holder the right to buy 1/20 share of NeuroSense Therapeutics Ltd. at $120.00 per share, until December 13, 2026. The stock last closed at $1.26, below the strike, so the warrant is out of the money. NeuroSense Therapeutics Ltd. has a market value of about $41.02M. There are 1.66M listed warrants; exercising all of them would add 0.2% to the 32.56M shares outstanding.
NeuroSense Therapeutics Ltd. reports its business to the SEC as “Pharmaceutical Preparations”, with its head office in Herzliya, Israel; it is incorporated in Israel. Its latest SEC filing was on November 18, 2026: report from a foreign company, form 6-K. The warrant closed at $0.0055 on November 16, 2026, down 98% from $0.3300 on November 17, 2025. NRSN trades at 1.1% of the strike; it would have to rise about 95-fold to reach it.
Thinly traded: NRSNW traded about $43 a day over the last 30 days, and on only 12 of 22 trading days. With so little trading you may not be able to buy or sell near the price shown; use a limit order.
Key terms
- Strike per share
- $120.00
- Shares per warrant
- 1/20
- Cash to exercise one warrant
- $6.00
- Expiry
- 2026-12-13
- Redemption trigger
- none stated
- Cashless exercise
- allowed
- Break-even stock price
- $120.11
Checked against the issuer's SEC filing of 2026. The terms were first set out in its F-1/A of 2024-05-20.
Exercise calculator
Each warrant buys 1/20 share at $120.00. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- NeuroSense Therapeutics Ltd.
- Underlying stock
- NRSN
- Share price
- $1.26
- Market cap
- $41.02M
- Shares outstanding
- 32.56M
- 12-month range
- $1.26 – $24.80
- 12-month change
- -95%
- Value of all listed warrants
- $9.10K (0.0% of market cap)
- Industry
- Pharmaceutical Preparations
- Head office
- Herzliya, Israel
- Incorporated in
- Israel
Market cap is the last share price times shares outstanding (as of 2025-12-31). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Model value Pro · free for now
- Last price
- $0.0055
- Stock volatility, measured
- 101%
- Volatility we use
- 50% · 66% · 100%
- Volatility the price implies
- 866%
- Method
- exact Black-Scholes formula
The estimate uses a volatility below the one measured, because measured volatility overstates what the market pays for. Not investment advice.
Dilution
- Shares outstanding
- 32.56M
- Listed warrants
- 1.66M
- Dilution if all exercised
- 0.2%
Warrant count from the notes to the company's financial statements. Confidence: medium.
Filings
- 6-KReport from a foreign company
- 6-KReport from a foreign company
- 6-KReport from a foreign company
- 6-KReport from a foreign company
- 6-KReport from a foreign company
- 6-KReport from a foreign company
- 6-KReport from a foreign company
- 6-KReport from a foreign company
- 6-KReport from a foreign company
- 6-KReport from a foreign company
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
- Reverse split 1:20
- Terms checked against an SEC filing
Questions about NRSNW
When does the NRSNW warrant expire?
NRSNW expires on December 13, 2026.
What is the strike price of NRSNW?
$120.00 per share; each warrant converts into 1/20 share, so exercising one warrant costs $6.00.
Can NeuroSense Therapeutics Ltd. redeem the NRSNW warrants early?
The source filing we read lists no stock-price redemption trigger.
How many NRSNW warrants are outstanding?
1.66M listed warrants, equal to 0.2% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow NRSNW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

